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Abstract: Diagnosis of tuberculosis from different body fluids remains challenging due to various limitations of the 
conventional and molecular methods. We studied the role of adenosine deaminase (ADA) assay to diagnose tubercular infection 
in cerebrospinal fluid, peritoneal fluid and pleural fluid. Fifty three patients with tubercular meningitis, peritonitis and pleuritis 
were enrolled in this study on the basis of clinical, radiological, cytological, biochemical and somewhere bacteriological 
evidences. Cases positive by AFB smear, culture or PCR were considered as confirmed TB and other as probable TB cases. 
Another 28 non-TB cases were included as control. In 53 suspected TB cases ADA was found positive in highest 42 (79.2%) 
cases, whereas smear and/ culture in 10 (18.7%) and PCR in 18 (33.9%) cases. ADA assay revealed 100% positivity in confirmed 
TB cases and 14.3% in non TB cases. The sensitivity and specificity of ADA was found 79% and 86% respectively when the cut 
off value was used ≥ 10 IU/L for CSF and ≥ 40 IU/L for pleural or peritoneal fluid. Mean ADA values of confirmed and probable 
TB cases were found significantly higher than that of non TB cases (< 0.05). Significance of difference was determined by 
ANOVA and Kruskal-Wallis test. Thus, adenosine deaminase assay in body fluids has proved to be efficient, reliable and simple 
method to diagnose tubercular meningitis, peritonitis and pleuritis. 
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1. Introduction 
Tuberculosis (TB) is a protean disease caused by 
Mycobacterium tuberculosis (M. tuberculosis). Usually TB 
patients present with pulmonary manifestations. But 
extrapulmonary tuberculosis (EPTB) is not uncommon in TB 
endemic countries like Bangladesh. EPTB comprises 10-15% 
of all TB cases in developing countries [1,2]. Pleural 
tuberculosis is one of the commonest forms of EPTB which is 
frequently presented with pleural effusion [3,4]. Likewise, 
about 78% tubercular peritonitis cases are presented with 
peritoneal effusion or ascites [5]. Another form of EPTB is 
tubercular meningitis which has most dangerous sequel if not 
treated promptly. Pleural and peritoneal tuberculosis is also to 
be treated as early as possible to minimize morbidity and 
mortality. 
Diagnosis of TB from body fluids like pleural, peritoneal 
and cerebrospinal fluid (CSF) is challenging as all these fluid 
samples possess very few bacilli. Conventional methods like 
microscopy and culture are widely used for diagnosis, but 
sensitivity of AFB (Acid fast bacilli) smear is only 5-20% and 
culture takes about three to six weeks time which may prolong 
the initiation of treatment. [6-9]. Histological evaluation 
following laparoscopy and/or biopsy in case of pleural and 
peritoneal TB brings about better sensitivity, also in smear and 
culture of the biopsy material [8,10]. But these methods are 
invasive, require greater expertise and may have sampling 
error and associated risk of complications [9,10]. Owing to 
this fact, many newer tests like antigen-antibody detection, 
antibody in lymphocyte supernatant (ALS) assay, cellular 
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IFN-γ release assays (IGRAs) and T-Spot have been 
developed [11]. But reliability of these tests in diagnosing 
active TB disease is not proven yet. With the advent of 
molecular technology polymerase chain reaction (PCR) has 
been developed for rapid detection of M. tuberculosis. PCR 
can reliably detect very low concentration of organism in 
extrapulmonary samples [5,12]. But requirement of dedicated 
laboratory areas, rigorous quality control and high cost of the 
test limits its routine use in resource poor countries. In this 
regard, adenosine deaminase (ADA) assay has shown to be a 
useful biochemical test in diagnosing TB from different body 
fluids, particularly in areas where the disease is prevalent 
[13-19]. 
ADA is an enzyme that catalyzes the deamination reaction 
which converts adenosine to inosine during proliferation and 
differentiation of lymphocytes. It also plays critical role in 
maturation of monocytes, thereby converts them into 
macrophage. So, ADA is being used as a biomarker of T cell 
activation and the conditions where macrophages are being 
infected. The level of ADA increases in biological fluids 
during tubercular infection due to stimulation of T cells by 
mycobacterial antigens [13]. 
As a TB-endemic country, a substantial number of EPTB 
cases are being reported each year with tubercular meningitis, 
peritonitis and pleuritis in Bangladesh. Major hindrance in the 
management of these EPTB cases is lack of a rapid, accurate 
and most importantly convenient diagnostic tool. Notably, 
under National Tuberculosis Program (NTP) AFB microscopy 
remains the single available laboratory test to detect TB cases 
in vast area of Bangladesh. So, the present situation does not 
permit to adopt newer molecular tests and even AFB culture as 
a routine method for TB diagnosis. ADA assay has been 
reported as rapid and cost effective method which can be 
adopted in even primary healthcare settings in developing 
countries. Moreover, many studies have confirmed the high 
sensitivity and specificity of this assay for early diagnosis of 
extrapulmonary TB, such as tuberculous pleuritis, pericarditis 
and meningitis [13-19]. To our knowledge no study has been 
done in Bangladesh by comparing its efficacy with that of 
conventional methods as well as molecular techniques. In the 
present study we aimed to evaluate the utility of adenosine 
deaminase (ADA) assay in detecting M. tuberculosis 
infections in CSF, pleural fluid and peritoneal fluid in 
comparison to conventional bacteriological methods and 
PCR. 
2. Materials and Methods 
This cross sectional study was conducted in the Department 
of Microbiology and Immunology, Bangabandhu Sheikh 
Mujib Medical University (BSMMU), Dhaka, Bangladesh in 
the year 2011. Clinical samples were collected from Dhaka 
Medical College Hospital and National Institute of Diseases of 
the Chest and Hospital (NIDCH), Dhaka. 
2.1. Selection of Cases 
Total 53 suspected TB cases either tuberculous pleuritis, 
peritonitis or meningitis was included in the study that 
fulfilled the following criteria. Notably, samples were 
collected before starting the anti-TB drugs. 
a) Strong clinical suspicion of TB based on history and 
radiological evidences. 
b) Cerebrospinal fluids having raised protein levels (≥ 0.45 
g/L) and/or decreased glucose (≤ 2.5 mmol/L or less than 
2/3 of blood sugar) and/or lymphocytic pleocytosis (≥ 50% 
lymphocytes). 
c) Pleural and peritoneal fluids having raised protein levels 
(3 g/dl) and/or lymphocytic pleocytosis (≥ 50% 
lymphocytes) 
d) Revealed no growth in routine bacteriological culture 
media. 
Another 28 cases of different clinical entity other than TB 
were taken as non TB control. CSF was collected from 
patients diagnosed as pyogenic meningitis (6), benign 
intracranial hypertension (2) and hydrocephalus (2), Pleural 
fluid from pleural empyema (5), nephrotic syndrome (2) and 
pleural malignancy (3); peritoneal fluid from chronic liver 
disease (5) and nephrotic syndrome (3). Diagnosis of the 
control cases were confirmed clinically and by appropriate 
laboratory tests. 
2.2. Categorization of Cases 
All the CSFs, pleural fluids and peritoneal fluids were 
undergone AFB microscopy, culture in Lowenstein-Jensen 
medium and PCR using IS6110 primer. On the basis of 
bacteriological evaluation suspected TB cases were then 
grouped into two categories. 
1. Confirmed TB cases: Positive for M. tuberculosis either 
in AFB smear, culture or PCR. 
2. Probable TB cases: Fulfilled the above mentioned 
inclusion criteria but negative in bacteriological tests. 
2.3. Laboratory Procedures 
2.3.1. Sample Processing 
About 2-3 ml CSF, 20-30 ml Pleural fluid and 100-200 ml 
peritoneal fluid were collected from each patient by trained 
physician under aseptic condition. One ml of each specimen 
was subjected to biochemical, cytological and routine 
bacteriological tests. Remaining specimens were then 
centrifuged for 15 minutes (CSF at 10000 rpm and 
pleural/peritoneal fluid at 3000 rpm) and deposits were used 
for staining, culture and PCR assay. Supernatant was 
preserved at -20°C for ADA assay. 
2.3.2. AFB Smear and Culture 
For detection of M. tuberculosis Ziehl-Neelsen staining and 
then culture in Lowenstein-Jensen medium was performed. 
2.3.3. ADA Assay 
Adenosine deaminase level was determined from the 
supernatants of the centrifuged specimens. A commercial 
adenosine deaminase assay kit (Diazyme laboratories, USA) 
was used which follows the principle of modified Giusti 
method [13,14,20]. Cut-off value for tuberculosis was 
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considered as ≥ 10 IU/L in CSF and ≥ 40 IU/L in pleural or 
peritoneal fluid [6,7,13]. 
2.3.4. Detection of M. Tuberculosis DNA 
(i). Extraction of DNA 
The pellet was re-suspended in 135 µl of lysis buffer 
[Prepared by mixing 20 µM Tris/HCl (pH 8.3), 1mg/ml 
proteinase K, 0.5% Tween 20 and 10 ml sterile distilled water] 
and then incubated at 56°C for 3 hours. At the end of 
incubation lysate was centrifuged at 12000 rpm for 15 min and 
resultant pellet was resuspended with 100 µl distilled water. 
This suspension was boiled at 95°C for 30 minutes in a water 
bath and then sonicated in an ultrasonication bath for 15 min. 
Then centrifuged at 10,000 rpm for 5 minutes; supernatant 
was recovered and stored at 4°C [21]. 
(ii). Amplification of DNA by PCR 
PCR was performed to amplify 123 bp of template targeting 
IS6110 element. Following primers were used- 
IS-F 5’-CCT GCG AGC GTA GGC GTC GG- 3' and 
IS-R 5'- CTC GTC CAG CGC CGC TTC GG-3' 
The 25 µl reaction mixtures contained 5X PCR buffer; 
1.5mM of MgCl2; 10 mM dNTPs 0.2mM of primers, 1 units 
of Taq DNA Polymerase and 5µl of the DNA. Conditions 
followed were initial denaturation at 94°C for 5 minutes, 
followed by 31 cycles at 94°C for 45 sec, 68°C for 45 sec and 
72°C for 2 minutes and final extension at 72°C for 10 minutes. 
To eliminate false positive or false negative results each run 
of the PCR assay included one positive control (DNA of 
H37RV strain) and one negative control (PCR grade water). 
(iii). Detection of Amplified DNA by Gel Electrophoresis 
The amplified products were subjected to electrophoresis 
on a 1.5% agarose gel containing 0.5 µg/ml ethidium bromide 
and after illumination of the gel under U-V light results were 
documented in gel documentation system (BIORAD, Italy). 
2.4. Statistical Analysis 
All the data were analyzed using Statistical Package for 
Social Science (SPSS) 11.5 software for windows. To test the 
significance of difference between different groups ANOVA 
was used for normally distributed variables, whereas the 
Kruskal-Wallis test was used for variables having non-normal 
distribution. P value < 0.05 was taken as minimum level of 
significance. As the rate of positivity by AFB smear and 
culture is very low sensitivity and specificity of ADA assay 
was calculated considering 53 TB cases as disease positive 
and 28 control cases as disease negative. 
2.5. Ethical Consideration 
Ethical clearance from the Institutional Ethical Review 
Committee was taken and informed written consent was 
sought from the patients before commencing the study. 
3. Results 
3.1. Results of AFB Smear, Culture, PCR and ADA Assay in 
the Study Population 
Out of 53 suspected TB samples highest 42 (79.2%) was 
positive by ADA. Only 10 (18.7%) samples were positive by 
AFB smear and culture. IS6110 PCR was found positive in 18 
(33.9%) cases (Table 1). AFB smear, culture and PCR all 
together improved the sensitivity to 19 (35.8%). These 19 
cases were considered as confirmed TB cases, while rest of the 
suspected cases was regarded as probable TB cases. All the 28 
samples from non TB control were found negative by AFB 
smear, culture or PCR. 
Table 1. AFB smear, culture, PCR and ADA positivity in suspected TB and non TB cases. 
Specimen No of cases 
Positive by 
Smear or culture 
n (%) 
PCR 
n (%) 
Smear, culture or PCR 
n (%) 
ADA 
n (%) 
CSF 27 
5 
(18.5) 
9 
(33.3) 
9 
33.3) 
23 
(85.1) 
Peritoneal fluid 10 
2 
(20.0) 
2 
(20.0) 
2 
(20.0) 
7 
(70.0) 
Pleural fluid 16 
3 
(18.8) 
7 
(43.7) 
8 
(50.0) 
12 
(75.0) 
Total 53 
10 
(18.7) 
18 
(33.9) 
19 
35.8) 
42 
(79.2) 
NB: All the non-TB samples were subjected to AFB smear, culture and PCR where none of the specimen was found positive. 
3.2. Comparative ADA Positivity among Confirmed, 
Probable and Non TB Cases 
While considering ADA positivity in confirmed and 
probable TB cases (Table 2), there was 100% positivity in all 
types of samples. About 67.6% probable cases were found 
positive for ADA, where pleural fluid showed the highest 
recovery rate of 70%. ADA was higher than the cut-off value 
in 2 CSFs and 2 pleural fluids, together comprises 14.3% of 
the non TB cases. As the control cases were selected on the 
basis of detailed diagnostic evidences, these 14.3% cases 
indicated false positivity by ADA. 
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Table 2. Comparison of ADA positivity among confirmed, probable and non TB cases. 
Cases 
ADA positivity in 
CSF Peritoneal fluid Pleural fluid Total 
Confirmed TB cases 
9 (100%) 
(n=9) 
2 (100%) 
(n=2) 
8 (100%) 
(n=8) 
19 (100%) 
(n=19) 
Probable TB cases 
12 (66.7%) 
(n=18) 
5 (62.5%) 
(n=8) 
6 (75%) 
(n=8) 
23 (67.6%) 
(n=34) 
Non TB cases 
2 (20%) 
(n=10) 
0 (0%) 
(n=8) 
2 (20%) 
(n=10) 
4 (14.3%) 
(n=28) 
 
3.3. Mean ADA Value of CSF, Peritoneal Fluid and Pleural 
Fluid in the Study Population 
Mean ADA value in confirmed TB cases were 17.9 ± 2.7, 
96.3 ± 24.1and 71.9 ± 32.7 respectively in CSF, peritoneal 
fluid and pleural fluid. These values were significantly higher 
than 5.3 ± 4.1, 11.1 ± 9.6, 20.6 ± 16.9 values of non TB cases. 
The values for the same samples in probable TB cases were 
16.8 ± 5.5, 54.5 ± 28.6 and 52.5 ± 31.0 which were also 
significantly higher than those of the non TB cases (Table 3). 
In each of the comparison p value was found ≤0.05. 
The sensitivity and specificity of ADA was found 79% and 
86% respectively when the cut off value used ≥ 10 IU/L in 
CSF and ≥ 40 IU/L in pleural or peritoneal fluid. 
Table 3. Mean ADA values of CSF, peritoneal fluid and pleural fluid in confirmed, probable and non TB cases. 
Samples 
ADA value in IU/L (Mean ± SD) 
CSF Peritoneal fluid Pleural fluid 
Confirmed TB group 17.9 ± 2.7 96.3 ± 24.1 71.9 ± 32.7 
Probable TB group 16.8 ± 5.5 54.5 ± 28.6 52.5 ± 31.0 
Non TB group 5.3 ± 4.1 11.1 ± 9.6 20.6 ± 16.9 
 
4. Discussion 
As Bangladesh is TB-endemic country a considerable 
number of TB patients are presented with tuberculous pleuritis, 
peritonitis or meningitis. Due to lack of appropriate laboratory 
methods, the diagnosis of these cases largely depends on 
clinical suspicion and non-microbiological parameters. 
Consequently, the cases having atypical clinical presentation 
remain undiagnosed and even untreated. In this cross sectional 
study, out of 53 suspected TB samples only 18.7% revealed 
smear and culture positivity. The poor sensitivity of AFB 
smear and culture has widely been reported in many other 
studies [6-9]. 
The present study demonstrated 33.9% PCR positivity 
among suspected TB cases which was higher than that of the 
bacteriological methods. But this rate of PCR positivity is 
inferior comparable to different other studies done with body 
fluids [7,12,22]. PCR positivity largely depends on sample 
volume, processing, stringent operation and expertise. As a 
result several authors reported varying degree of sensitivity of 
this test. Another inconvenience of PCR in body fluids is 
presence of inhibitors, which negatively influence the result. 
This problem can be overcome by a multistep process of 
removing PCR inhibitors and thus improve the recovery of 
purified M. tuberculosis DNA [22]. Most importantly in this 
study PCR was performed targeting IS6110 gene sequence 
which is recently been reported to be absent in genome of 
some isolates of M. tuberculosis in south-east India, Tanzania, 
Malaysia, Oman and Denmark [23,24]. So, IS6110 PCR result 
sometimes found negative in TB cases. Use of combination of 
primers targeting different site of mycobacterial genome or 
using nested PCR may improve the detection of M. 
tuberculosis. 
In 53 suspected TB cases adenosine deaminase assay 
demonstrated highest positivity among all the methods 
applied in this study. In about 85% CSF ADA value exceeded 
the diagnostic cut-off for tuberculosis. For peritoneal and 
pleural fluid raised ADA value was found in 70% and 75% 
cases, respectively. In a considerable number of suspected TB 
cases (11 out of 53) ADA activity was found negative. In this 
study, besides bacteriological confirmation, cases enrolled on 
the basis of clinical, radiological or cytological (≥50% 
lymphocytes) evidences. So, there may be some overlapping 
features with other clinical conditions that influenced the 
results. Nevertheless, in this study bacteriologically confirmed 
all the 19 cases (100%) showed a distinct higher value of ADA 
which signifies the precision of this test. Moreover, among 
bacteriologically negative 34 probable TB cases 67.6% cases 
was found positive with highest detection rate in pleural fluid 
(75%). This finding is in concordance with the study of 
Kashyap et al. who found 96% sensitivity in culture positive 
CSF and 78% in culture negatives [16]. Ocana et al. and 
Martinez- Vazquez et al found 100% positivity of ADA assay 
in culture positive pleural and peritoneal fluids respectively 
[17,18]. In addition, the mean ADA value of confirmed TB 
and probable TB cases was found significantly higher than 
that of non TB cases (P < 0.05) which indicates the strong 
relationship between presences of TB infection and ADA 
activity. 
As discussed earlier, the sensitivity of AFB smear and 
culture is very low in diagnosing extrapulmonary TB. Thus it 
is not reliable to judge any other tests considering these 
methods as gold standard. Therefore, in the present study a 
suspected TB case was regarded as disease positive and 
against this variable sensitivity of ADA was found 79.2%. Out 
of 28 cases in the non TB control group two CSFs and two 
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pleural fluids revealed ADA positivity, consequently 
specificity of the test found 85.7%. Of note, in few other 
conditions other than TB like pyogenic meningitis and 
empyema where fluids contain high cell counts can depict 
high total ADA value. It makes dilemma in differentiating non 
tubercular conditions from tuberculous origin. ADA value 
detected in most of the assays is the total ADA which includes 
both ADA-1 and ADA-2 isoenzymes. In tubercular disease 
particularly elevated isoform is ADA2 which gives rise to the 
elevation of total ADA also [9,13]. So, analysis of specific 
ADA2 isoenzyme may help to correctly classify these cases. 
Furthermore, the sensitivity and specificity of ADA largely 
depends upon the setting of cut-off values [7,13,16,19]. Thus 
specificity can be improved by elevating the cut-off value and 
overlapping values between suspected TB and non TB cases 
can be avoided. 
5. Conclusion 
In conclusion, adenosine deaminase level in body fluids is a 
good indicator of extrapulmonary TB especially where 
clinical suspicion is high. It can be performed with minimum 
time, cost and equipments compared to PCR. However, 
culture is still the gold standard and superior to ADA in 
determining drug resistance prior initiation of treatment. So, 
for achieving best clinical outcome ADA values should be 
carefully correlated with the clinical and other biochemical 
parameters and cases should be confirmed bacteriologically 
where facility is available. Meanwhile empirical treatment can 
be employed in patients having high ADA value as it 
efficiently differentiates TB from non-TB cases. 
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